RxDoctor Payments Data

Cindy Mesmer

Family · Hyannis, MANPI 1326478728

Payments from drug & device makers

$4,094in general payments, 2019–2025

Across 163 payments — averaging $25.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$431
  • Sumitomo Pharma America, Inc.$413
  • Tolmar, Inc.$379
  • Endo USA, Inc.$256
  • AbbVie$248
  • Johnson & Johnson$232
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$4,05899%
  • Education$361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,094 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.

See all family providers in Massachusetts

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron101$100,781
MyrbetriqMirabegron66$59,908
Methenamine Hippurate120$7,825
Estradiol65$4,755
Tamsulosin Hcl182$3,286
Finasteride166$2,535
Oxybutynin Chloride ErOxybutynin Chloride55$2,303
Alfuzosin Hcl ErAlfuzosin Hcl92$1,651
Solifenacin Succinate23$1,319
Trospium Chloride19$879
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst51$609
Potassium Citrate ErPotassium Citrate12$253
Imipramine Hcl24$202
CefuroximeCefuroxime Axetil17$197
Megestrol Acetate12$156

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$413$100,781101 claims
Astellas Pharma US IncMyrbetriq$103$59,90866 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,320 family providers in Massachusetts.

Other family in Hyannis

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →